Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
06/2006
06/21/2006EP1506193B1 Carbamate-substituted pyrazolopyridines
06/21/2006EP1366049B1 Pirazino¬1'2':1,6|pyrido¬3,4-b|indole derivatives
06/21/2006EP1255734B1 Isatine derivatives with neurotrophic activity
06/21/2006CN1791601A Azaindole-derivatives as factor Xa inhibitors
06/21/2006CN1791598A Benzimidazole-derivatives as factor Xa inhibitors
06/21/2006CN1789265A Novel substituted 1H-pyrrolo[2,3-b]pyridines and preparation thereof
06/21/2006CN1789246A Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
06/21/2006CN1260227C 5-membered ring heterocyclic compounds with nitrogen
06/21/2006CN1260225C Tetrahydropyridino or piperidino hetlrocyclic derivatives
06/21/2006CA2530964A1 Crystalline form of rabeprazole sodium
06/20/2006US7064215 Nitrogen compounds such as 3-(5-morpholin-4-yl-1H-benz-imidazol-2-yl)-1H-indazole and/or isomers, used as immunology modulators, antidiabetic agents, antiogenesis inhibitors or for prophylaxis of Alzheimer's disease
06/20/2006US7064212 Dicationic viologens, such as methyl viologen and benzyl viologen, associated with anions selected from bis(trifluoro-methyl(or perfluoroethyl)sulfonyl)imide and tris(trifluoro-methylsulfonyl)methide; soluble in quat ammonium melts
06/20/2006US7064211 Hemiasterlin derivatives and uses thereof
06/20/2006US7064142 Imidazonline compounds
06/20/2006US7064120 For prevention and/or suppression of preterm labor, suppression of labor at term prior to caesarean delivery, and for the treatment of dysmenorrhea; useful in enhancing fertility rates
06/20/2006US7064117 Anti-cancer 2,3-dihydro-1H-pyrrolo[3,2-f]quinoline complexes of cobalt and chromium
06/20/2006US7063832 Treating musculoskeletal pain or restless leg syndrome by breathing a muscle relaxant condensation aerosol having a mass median aerodynamic diameter (MMAD) of <3 mu m and <5% relaxant degradation products; kits; heating a coating of drug on a support to vaporize and passing air through the heated vapors
06/20/2006US7063831 Delivery of erectile dysfunction drugs through an inhalation route
06/20/2006US7063830 condensation aerosol for delivery of lidocaine, verapamil, diltiazem, isometheptene and lisuride, wherein aerosol is formed by heating a thin layer containing the drug, on a solid support, to produce a vapor of the drug, and condensing the vapor to form aerosol
06/20/2006CA2177392C Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
06/15/2006WO2006063167A1 1h-pyrrolo[2,3-b]pyridines
06/15/2006WO2006062658A1 Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4] triazol-1-yl)-1h-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
06/15/2006WO2006062224A1 Carboxamide derivative
06/15/2006WO2006061791A2 Novel diazabicyclononene derivative
06/15/2006WO2006061711A1 1, 2, 3, 3a, 8, 8a-hexahydro-2, 7a-diada-cyclopenta [a] inden-7-one derivatives which bind to neuronal nicotinic acetylcholine specific receptor sites and are useful in modulating cholinergic function and in the treatment of addictive disorders
06/15/2006WO2006061217A2 Saquinavir derivatives useful in immunoassay
06/15/2006WO2006061212A1 3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors
06/15/2006WO2006060919A1 Novel spirotropane compounds and methods for the modulation of chemokine receptor activity
06/15/2006WO2006060918A1 Novel spirotropane compounds and methods for the modulation of chemokine receptor activity
06/15/2006WO2006044573A3 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof
06/15/2006WO2006036816A3 Chemical compounds
06/15/2006WO2006027370A8 PREPARATION OF 9-HYDROXY-3- (2-HYDROXYETHYL) -2-METHYL-4H-PYRID0[1, 2-a] PYRIMIDIN-4-ONE AND CRYSTALS THEREOF
06/15/2006WO2006026196A3 Androgen receptor modulators
06/15/2006US20060128957 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof
06/15/2006US20060128761 Novel triazole compounds as transforming growth factor (TGF) inhibitors
06/15/2006US20060128756 Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses
06/15/2006US20060128750 Targeting chemokine receptors and interfere with the binding of the natural ligand thereto; antagonists or agonists; protecting target cells from HIV infection; treating HIV or FIV infected patients
06/15/2006US20060128748 Bicyclic triazole alpha4 integrin inhibitors
06/15/2006US20060128746 Methods, kits and compositions for using pyrrole derivatives
06/15/2006US20060128745 Chemical compounds
06/15/2006US20060128740 Tricyclic androgen receptor modulator compounds and methods
06/15/2006US20060128736 Camptothecin-carboxylate formulations
06/15/2006US20060128732 enzyme inhibitor of phosphotidylinositol-3-kinase (PI3K); N-(7,8-dimethoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)nicotinamide; antiinflammatory agent, immunomodulators; asthma, dermatitis, rhinitis, allergic diseases, chronic obstructive pulmonary disease, rheumatoid arthritis, Graves' disease
06/15/2006US20060128710 Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof
06/15/2006US20060128700 e.g. 2-[1-(2-Fluorobenzyl)-1H-indazol-3-yl]-5-(3-oxa-9-azabicyclo[3.3.1]non-9-yl)-4pyrimidinylamine; soluble guanylate cyclase stimulant; neurodegenerative diseases, cognition activator; Alhzeimer's, Parkinson's disease, Pick's syndrome, multiple sclerosis, HIV dementia, schizophrenia
06/15/2006US20060128692 Non nucleoside reverse transcriptase inhibitors
06/15/2006US20060128687 Lactam glycogen phosphorylase inhibitors and method of use
06/15/2006US20060128680 porosity; nanostructure
06/15/2006US20060128674 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents
06/15/2006US20060128669 3-(4-Fluorobenzyl)-8-hydroxy-quinoline-5,7-dicarboxylic acid 7-methylester; against Human T Cell leukemia virus, Feline and Simian immunodeficiency viruses, AIDS and related clinical symptoms
06/15/2006US20060128661 Novel substituted 1H-pyrrolo[2,3-b]pyridines and preparation thereof
06/15/2006CA2591330A1 1, 2, 3, 3a, 8, 8a-hexahydro-2, 7a-diada-cyclopenta [a] inden-7-one derivatives which bind to neuronal nicotinic acetylcholine specific receptor sites and are useful in modulatingcholinergic function and in the treatment of addictive disorders
06/15/2006CA2590737A1 Novel spirotropane compounds and methods for the modulation of chemokine receptor activity
06/15/2006CA2590711A1 Antagonists to the vanilloid receptor subtype 1 (vr1) and uses thereof
06/15/2006CA2590141A1 Saquinavir derivatives useful in immunoassay
06/15/2006CA2589966A1 Novel diazabicyclononene derivative
06/15/2006CA2589448A1 Substituted imidazo[4,5-b]pyridines as inhibitors of gastric acid secretion
06/15/2006CA2589127A1 3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors
06/15/2006CA2587936A1 Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites
06/15/2006CA2587508A1 Novel spirotropane compounds and methods for the modulation of chemokine receptor activity
06/14/2006EP1669357A1 SUBSTANCE WHICH EXHIBITS ANTIVIRAL AND ANTIBACTERIAL ACTIVITY AND IS BASED ON DERIVATIVES OF 2,8-DITHIOXO-1H-PYRANO 2,3D&cedi l;6,5-D DIPYRIMIDYNE AND 10-AZA-ANALOGUE THEREOF
06/14/2006EP1668014A2 Fused heterocyclic compounds as serotonin receptor modulators
06/14/2006EP1668010A2 Method of preparing 4-amino-1h -imidazo(4,5- c )quinolines and acid addition salts thereof
06/14/2006EP1668009A1 Hcv inhibitors and methods of using them
06/14/2006EP1668000A1 Pyrimidin-2-amine derivatives and their use as a2b adenosine receptor antagonists
06/14/2006EP1667994A1 Quinolone antibacterial agents
06/14/2006EP1667982A2 Isoquinolinone potassium channel inhibitors
06/14/2006EP1667685A1 Quinazoline potassium channel inhibitors
06/14/2006EP1497292B1 Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents
06/14/2006EP1379618B1 Ligand and complex for catalytically bleaching a substrate
06/14/2006EP1377577B1 Pyrrole derivates for treating cytokine mediated diseases
06/14/2006EP1165085B1 Phthalazine derivatives for treating inflammatory diseases
06/14/2006EP1157704B1 Spla2 inhibitors for the treatment of ischaemic reperfusion injury
06/14/2006CN1788068A Luminescent-polymer composition
06/14/2006CN1788000A Phthalazinone derivatives
06/14/2006CN1787994A 2,4,6-phenyl substituted cyclic ketoenols
06/14/2006CN1787818A Amino cyclobutylamide modulators of chemokine receptor activity
06/14/2006CN1785998A N,N-dipyridyl 3,4,9,10-tetraformyl diimine derirative and its synthesis method
06/14/2006CN1259307C Acylated indanyl amines and their use as pharmaceuticals
06/13/2006USRE39128 Antibacteria drug; respiratory system disorders; otitis
06/13/2006US7060850 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof
06/13/2006US7060832 Nitrogen-containing fused heterocyclic carboxylic acids having an absolute configuration of “R”
06/13/2006US7060831 Process for the preparation of tetrahydrothieno[3,2-c] pyridine derivatives
06/13/2006US7060830 Central nervous system disorders; antibiotics; viricides; antitumor agents; psychological disorders
06/13/2006US7060828 Angiogenosis inhibitor; anticancer agents
06/13/2006US7060722 Proline derivatives and use thereof as drugs
06/13/2006US7060720 Compounds useful for treating or preventing IMPDH associated disorders, such as transplant rejection and autoimmune diseases and inhibitors of inosine-5'-monophosphate dehydrogenase). The compounds and pharmaceutical compositions
06/13/2006US7060710 Isoxazole pyrazoloindane derivatives as cognition enhancing GABAA α5 subtype ligands
06/13/2006US7060705 2-(saturated N-heterocycylalkyl) quinazolinone compounds, e.g., 3-benzyl-2-[1-(4-methylpiperazin-1-yl)propyl]quinazolin-4(3H)-one, used to treat cancer, especially histiocytic lymphoma, lung adenocarcinoma, small cell lung cancer, pancreatic cancer, glioblastoma and breast carcinoma
06/13/2006US7060700 Amide derivatives useful as inhibitors of the production of cytokines
06/13/2006US7060699 Aryl and heteroaryl diazabicycloalkanes, their preparation and use
06/13/2006US7060254 Aerosol; heating thin film on solid support; vaporization with air flow
06/13/2006CA2268954C Oxadiazoles, processes for their preparation and their use as medicaments
06/13/2006CA2260777C Pentafluorobenzenesulfonamides and analogs
06/13/2006CA2249562C Certain fused pyrrolecarboxamides as gaba brain receptor ligands
06/13/2006CA2131103C Pyrido[1,2,3-d,e][1,3,4]benzoxadiazine derivatives
06/08/2006WO2006131552A1 Alpha-carbolines as cdk-1 inhibitors
06/08/2006WO2006060678A2 Novel processes for the preparation of cgrp-receptor antagonists and intermediates thereof
06/08/2006WO2006059210A2 Fused bicyclic pyrrols as hmg-coa reductase inhibitors
06/08/2006WO2006059165A1 Pyrrolopyridine-2-carboxylic acid amide derivative useful as inhibitor of glycogen phosphorylase